The Tekla Funds (Healthcare, Life Sciences) invested in Oculis SA as part of a CHF 15.5 equity financing round. Oculis SA is biopharmaceutical Swiss Startup company…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Paolo Bossi
…
This content is for Standard 1 Year members only. LoginJoin Now